2Mattsson G, Jansson L, Nordin A, et al. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes, 2004, 53: 948-954.
3Talavera L, Crklos J, Garcza-Ocana A, et al. The edmonton rat:anexperimental modle of rat islet allotranapl-antation and glucocorticoid-free immunosuppression for the treatment of diabetes. Diabetes, 2002, 51(2): 625.
5Gaber AO, Chamsuddin A, Fraga D, et al. Insulin independence achieved using the transmesenteri approach to the portal vein for islet transplantation. Transplantat, 2004, 77(2): 309-311.
6Hirshberg B, Mog S, Patterson N, et al. Histopathological study of intrahepatic islets transplanted in the nonhuman primate modle using edomonton protocal immunosuppression. J Clin Endocrinol Metab,2002, 87(12): 5424-5429.
7Movabedi B, Keymeulen B, Lauwers MH, et al. Laparoscopie approach for human islet transplantation into a defined liver segment in type-1 diabetic patients. Transpl Int, 2003, 16(3): 186-190.
8Daniel R, White M, Nicholson SA, et al. Pancreatic islet cell transplantation: progress in the clinical setting. Treat Endocrinilogy, 2003, 2(3): 173-189.
9Morsiani E, Fogli T, Lanza G Jr, et al. Long-term insulin independence following repeated islet transplantation in titally pancratectomized diabetic pigs. Cell Transplant, 2002, 11(1): 55-56.
10Hirshberg B, Montgomery S, Mysoki MG, et al. Pancreatic islet transplantation using the nonhuman primate (rhesue) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. Diabetes, 2002, 51(7): 2135-2140.
